These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2095926)

  • 1. Serum cholesterol reduction with tamoxifen.
    Schapira DV; Kumar NB; Lyman GH
    Breast Cancer Res Treat; 1990 Nov; 17(1):3-7. PubMed ID: 2095926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tamoxifen treatment on serum cholesterol fractions in breast cancer women.
    Dziewulska-Bokiniec A; Wojtacki J; Skokowski J; Kortas B
    Neoplasma; 1994; 41(1):13-6. PubMed ID: 8202188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of the atherogenic amino acid homocysteine in post-menopausal women with breast cancer treated with tamoxifen.
    Anker G; Lønning PE; Ueland PM; Refsum H; Lien EA
    Int J Cancer; 1995 Jan; 60(3):365-8. PubMed ID: 7829246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Level of total cholesterol in serum of patients with breast cancer treated with tamoxifen].
    Wojtacki J; Dziewulska-Bokiniec A
    Pol Tyg Lek; 1993 Jun 7-14; 48(23-24):505-6. PubMed ID: 8170824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipids and lipoprotein alterations in tamoxifen-treated breast cancer women in relation to the menopausal status.
    Ilanchezhian S; Thangaraju M; Sachdanandam P
    Cancer Biochem Biophys; 1995 Nov; 15(2):83-90. PubMed ID: 8590439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy.
    Dnistrian AM; Schwartz MK; Greenberg EJ; Smith CA; Schwartz DC
    Clin Chim Acta; 1993 Dec; 223(1-2):43-52. PubMed ID: 8143369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.
    Akyol M; Alacacioglu A; Demir L; Kucukzeybek Y; Yildiz Y; Gumus Z; Kara M; Salman T; Varol U; Taskaynatan H; Oflazoglu U; Bayoglu V; Tarhan MO
    Cancer Biomark; 2017; 18(4):441-449. PubMed ID: 28106545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ; Hortobagyi GN
    Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of toremifene and tamoxifen on lipid profiles in post-menopausal patients with early breast cancer: interim results from a Japanese phase III trial.
    Tominaga T; Kimijima I; Kimura M; Takatsuka Y; Takashima S; Nomura Y; Kasumi F; Yamaguchi A; Masuda N; Noguchi S; Eshima N
    Jpn J Clin Oncol; 2010 Jul; 40(7):627-33. PubMed ID: 20382637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?
    Liberopoulos E; Karabina SA; Tselepis A; Bairaktari E; Nicolaides C; Pavlidis N; Elisaf M
    Oncology; 2002; 62(2):115-20. PubMed ID: 11914596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipoproteins and proteins after breast cancer surgery and effects of tamoxifen.
    Rössner S; Wallgren A
    Atherosclerosis; 1984 Sep; 52(3):339-46. PubMed ID: 6497936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer.
    Gylling H; Pyrhönen S; Mäntylä E; Mäenpää H; Kangas L; Miettinen TA
    J Clin Oncol; 1995 Dec; 13(12):2900-5. PubMed ID: 8523053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.
    Reis SE; Costantino JP; Wickerham DL; Tan-Chiu E; Wang J; Kavanah M
    J Natl Cancer Inst; 2001 Jan; 93(1):16-21. PubMed ID: 11136837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen therapy in breast cancer control worldwide.
    Love RR; Koroltchouk V
    Bull World Health Organ; 1993; 71(6):795-803. PubMed ID: 8313498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood chemistry profiles in menopausal women administered tamoxifen for breast cancer.
    Lox C; Ronaghan C; Cobos E
    Gen Pharmacol; 1998 Jan; 30(1):121-4. PubMed ID: 9457492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer.
    Ingram D
    Aust N Z J Surg; 1990 Sep; 60(9):673-5. PubMed ID: 2396945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer.
    Saarto T; Blomqvist C; Ehnholm C; Taskinen MR; Elomaa I
    J Clin Oncol; 1996 Feb; 14(2):429-33. PubMed ID: 8636753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.